Neuroblastoma in Adolescents and Adults: The Memorial Sloan-Kettering Experience

Medical and Pediatric Oncology

Volumn 41, Issue 6, 2003, Pages 508-515

  Kushner, Brian H ^a   Kramer, Kim ^a   LaQuaglia, Michael P ^a   Modak, Shakeel ^a   Cheung, Nai Kong V ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Adolescents; Chemotherapy; Immunotherapy; Neuroblastoma; Radiotherapy

Indexed keywords

ARYLBUTYRIC ACID DERIVATIVE; BUSULFAN; CARBOPLATIN; CIS RETINOIC ACID; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; FLUOROURACIL; GANGLIOSIDE ANTIBODY; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IFOSFAMIDE; MELPHALAN; METHOTREXATE; MONOCLONAL ANTIBODY; MONOCLONANT ANTIBODY 3F8; MYELOABLATIVE AGENT; RETINOIC ACID; THIOTEPA; TOPOTECAN; UNCLASSIFIED DRUG; VINCRISTINE;

ADOLESCENT; ADOLESCENT DISEASE; ADULT; ADULT DISEASE; ARTICLE; BONE MARROW PURGING; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; HYPOTENSION; LOW DRUG DOSE; MALE; NEUROBLASTOMA; PRELEUKEMIA; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SENSORY NEUROPATHY; STOMACH PARESIS; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOTHERAPY; MALE; NEUROBLASTOMA; PROGNOSIS; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 0242407205     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.10273     Document Type: Article

References (28)

1. Castleberry RP. Biology and treatment of neuroblastoma. Pediatr Clin N Am 1997;4:919-937.
2. Matthay KK. Neuroblastoma: Biology and therapy. Oncology 1997;11:1857-1866.
3. Evans AE, Silber JH, Shpilsky A, et al. Successful management of low-stage neuroblastoma without adjuvant therapies: A comparison of two decades, 1972 through 1981 and 1982 through 1992, in a single institution. J Clin Oncol 1996;14:2405-2410.
4. Matthay KK, Villablanca JG, Seeger RC, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. N Engl J Med 1999;341:1165-1173.
5. Finklestein JZ, Klemperer MR, Evans A, et al. Multiagent chemotherapy for children with metastatic neuroblastoma: A report from the Childrens Cancer Study Group. Med Pediatr Oncol 1979;6:179-188.
6. Blatt J, Gula MJ, Orlando SJ, et al. Indolent course of advanced neuroblastoma in children older than 6 years at diagnosis. Cancer 1995;76:890-894.
7. Franks LM, Bollen A, Seeger RC, et al. Neuroblastoma in adults and adolescents. An indolent course with poor survival. Cancer 1997;79:2028-2035.
8. Lopez R, Karakousis C, Rao U. Treatment of adult neuroblastoma. Cancer 1980;45:840-844.
9. Fiorillo A, Migliorati R, Fiore M. Late recurrence of disseminated neuroblastoma after 3 years of continuous remission. J Pediatr 1984;104:161-162.
10. Aleshire SL, Glick AD, Cruz VE, et al. Neuroblastoma in adults. Pathological findings and clinical outcome. Arch Pathol Lab Med 1985;109:352-356.
11. Allan SG, Cornbleet MA, Carmichael J, et al. Adult neuroblastoma. Report of three cases and review of the literature. Cancer 1986;57:2419-2421.
12. Kaye JA, Warhol MJ, Kretschmar C, et al. Neuroblastoma in adults. Three case reports and a review of the literature. Cancer 1986;58:1149-1157.
13. Prestidge BR, Donaldson SS. Treatment results among adults with childhood tumors: A 20-year experience. Int J Radiat Oncol Biol Phys 1989;17:507-514.
14. Moody AM, Norma AR, Tait D. Paediatric tumours in the adult population: The experience of the Royal Marsden Hospital 1974-1990. Med Pediatr Oncol 1996;26:153-159.
15. Kushner BH, LaQuaglia MP, Cheung N-KV, et al. Clinically critical impact of molecular genetic studies in pediatric solid tumors. Med Pediatr Oncol 1999;33:530-535.
16. Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993;11:1466-1477.
17. Kushner BH, Helson L. Coordinated use of sequentially escalated cyclophosphamide and cell-cycle-specific chemotherapy (N4SE protocol) for advanced neuroblastoma: Experience with 100 patients. J Clin Oncol 1987;5:1746-1751.
18. Kushner BH, O'Reilly RJ, LaQuaglia M, et al. Dose-intensive use of cyclophosphamide in ablation of neuroblastoma. Cancer 1990;66:1095-1100.
19. Kushner BH, LaQuaglia MP, Bonilla MA, et al. Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age. J Clin Oncol 1994;12:2607-2613.
20. Cheung N-KV, Kushner BH, LaQuaglia M, et al. N7: A novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age. Med Pediatr Oncol 2001;36:224-230.
21. Kushner BH, Kramer K, Meyers PA, et al. Pilot study of topotecan and high-dose cyclophosphamide for resistant pediatric solid tumors. Med Pediatr Oncol 2000;35:468-474.
22. D2 antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age. J Clin Oncol 1998;16:3053-3060.
23. Kushner BH, Cheung N-KV, Kramer K, et al. Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in children and young adults. Bone Marrow Transplant 2001;28:551-556.
24. D2monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma. J Clin Oncol 2001;22:4189-4194.
25. Kushner BH, Kramer K, Cheung N-KV. Oral etoposide for refractory and relapsed neuroblastoma. J Clin Oncol 1999;17:3221-3225.
26. Kushner BH, Wolden S, LaQuaglia MP, et al. Hyperfractionated low-dose (21 Gy) radiotherapy for high-risk neuroblastoma following intensive chemotherapy and surgery. J Clin Oncol 2001;19:2821-2828.
27. Kushner BH, O'Reilly RJ, Mandell LR, et al. Myeloablative combination chemotherapy without total body irradiation for neuroblastoma. J Clin Oncol 1991;9:274-279.
28. Nitschke R, Parkhurst J, Sullivan J, et al. Topotecan in pediatric patients with recurrent and progressive solid tumors: A Pediatric Oncology Group phase II study. J Pediatr Hematol/Oncol 1998;20:315-318.